Gene: GKN1
Official Full Name: gastrokine 1provided by HGNC
Gene Summary: The protein encoded by this gene is found to be down-regulated in human gastric cancer tissue as compared to normal gastric mucosa. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17373 | GKN1 Knockout cell line (HeLa) | Human | GKN1 | 1:3~1:6 | Negative | Online Inquiry |
GKN1 Gene Knockout Cell Lines are specially engineered cellular models that facilitate the study of the GKN1 gene's functions and its associated pathways. These cell lines are created through precise genetic engineering techniques, such as CRISPR-Cas9, which enable the intentional disruption or deletion of the GKN1 gene. This knockout approach allows researchers to explore the biological role of GKN1 in various physiological and pathological contexts, enhancing our understanding of its implications in diseases like inflammation, cancer, and metabolic disorders.
The primary function of GKN1 Gene Knockout Cell Lines is to provide a platform for detailed functional assays, protein expression studies, and genomic analyses. By disrupting the GKN1 gene, these cell lines help elucidate the molecular mechanisms through which this gene influences cell behavior, including proliferation, differentiation, and apoptosis. Researchers can utilize these lines to model disease states, explore novel therapeutic targets, and assess the potential effects of new drugs or compounds that may modulate GKN1 activity.
In terms of scientific importance, these knockout cell lines are invaluable in both basic research and clinical applications. Their ability to mimic disease-related alterations allows for more accurate studies of gene-environment interactions and the evaluation of treatment strategies. The insights gained from using GKN1 knockout models can lead to advancements in targeted therapies and precision medicine, which are critical for developing effective interventions.
Compared to other genetic models, GKN1 Gene Knockout Cell Lines offer unique advantages, including high specificity and the ability to provide reproducible and reliable data. Their creation employs robust editing techniques that are widely recognized for their efficiency and precision, making them superior to traditional models which may exhibit variability. This specificity not only enhances the research outcomes but also minimizes off-target effects, a crucial factor for experimental integrity.
For researchers, clinicians, and pharmaceutical companies, GKN1 Gene Knockout Cell Lines are valuable assets for driving innovation and knowledge into therapeutic approaches for diseases linked to GKN1. By leveraging these advanced models, users can uncover novel biological insights that have the potential to transform the landscape of disease treatment.
At [Your Company Name], we are dedicated to providing high-quality biological research tools, including the GKN1 Gene Knockout Cell Lines. Our expertise in genetic engineering and commitment to excellence ensures that our products support you in making groundbreaking contributions to science and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.